Almost one-quarter of European countries do not provide access to biologics for arthritis
Data from a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates the vast inequalities in access to biologics for the treatments of rheumatoid arthritis (RA) across ...
Jun 6, 2012